These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 32407143)

  • 1. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HEIH modulates CDK8 expression by inhibiting miR-193a-5p to accelerate nasopharyngeal carcinoma progression.
    Han YE; Tao JM; Wang SX; Ju X; Song ZY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):770-778. PubMed ID: 33577031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression
    Xu T; Lei T; Li SQ; Mai EH; Ding FH; Niu B
    World J Gastroenterol; 2020 Apr; 26(15):1745-1757. PubMed ID: 32351291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p.
    Li S; Zhang Q; Liu W; Zhao C
    BMC Cancer; 2021 Mar; 21(1):290. PubMed ID: 33736615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
    Wang L; He M; Fu L; Jin Y
    Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

  • 14. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
    Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
    Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 16. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01224 accelerates malignant transformation via MiR-193a-5p/CDK8 axis in gastric cancer.
    Sun H; Yan J; Tian G; Chen X; Song W
    Cancer Med; 2021 Feb; 10(4):1377-1393. PubMed ID: 33655711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR‑4656 to modulate CEMIP expression.
    Hu R; Lu Z
    Oncol Rep; 2020 Jan; 43(1):328-336. PubMed ID: 31746434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
    Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
    Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
    J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.